{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_thiazolidinediones",
          "name": "Thiazolidinediones"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_estrogens",
          "name": "Estrogens"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_oral_glucocorticoids",
          "name": "Oral glucocorticoids"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_atypical_antipsychotics",
          "name": "Atypical antipsychotics"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "name": "Sodium-glucose cotransporter-2 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_antiretroviral_agents",
          "name": "Antiretroviral agents"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_protease_inhibitors",
          "name": "Protease inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_exogenous_hormones",
          "name": "Exogenous hormones"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fibrates",
          "type": "Drug",
          "label": "Fibrates",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thiazolidinediones",
          "type": "Drug",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_estrogens",
          "type": "Drug",
          "label": "Estrogens",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_oral_glucocorticoids",
          "type": "Drug",
          "label": "Oral glucocorticoids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_atypical_antipsychotics",
          "type": "Drug",
          "label": "Atypical antipsychotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "type": "Drug",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antiretroviral_agents",
          "type": "Drug",
          "label": "Antiretroviral agents",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_protease_inhibitors",
          "type": "Drug",
          "label": "Protease inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_exogenous_hormones",
          "type": "Drug",
          "label": "Exogenous hormones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Severe hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_hypertriglyceridaemia",
          "type": "Condition",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot1",
          "type": "Target",
          "label": "Off-target Effects of Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp1",
          "type": "Pathway",
          "label": "Risk Pathway due to Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "Adverse Effects Due to Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Fibrates",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Niacin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Estrogens",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Oral glucocorticoids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Atypical antipsychotics",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Antiretroviral agents",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Protease inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Exogenous hormones",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_gemfibrozil",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知与高甘油三酯血症的相互作用"
        },
        {
          "source": "drug_fibrates",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通常用于治疗高甘油三酯血症，但在严重情况下需要谨慎"
        },
        {
          "source": "drug_niacin",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "高剂量可能导致甘油三酯升高"
        },
        {
          "source": "drug_thiazolidinediones",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "部分研究显示可能升高甘油三酯"
        },
        {
          "source": "drug_beta_blockers",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "部分β-adrenergic拮抗剂与甘油三酯升高相关"
        },
        {
          "source": "drug_estrogens",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "雌激素可能影响甘油三酯代谢"
        },
        {
          "source": "drug_oral_glucocorticoids",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知糖皮质激素可导致甘油三酯升高"
        },
        {
          "source": "drug_atypical_antipsychotics",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "与代谢综合征的关联可能影响甘油三酯水平"
        },
        {
          "source": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "潜在的代谢效应可能与甘油三酯有关"
        },
        {
          "source": "drug_antiretroviral_agents",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "某些抗病毒药物可能引起甘油三酯升高"
        },
        {
          "source": "drug_protease_inhibitors",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "此类药物已知与异常脂质代谢相关"
        },
        {
          "source": "drug_exogenous_hormones",
          "target": "Severe hypertriglyceridaemia",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "外源激素可能影响甘油三酯代谢"
        },
        {
          "source": "n_gemfibrozil",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能存在靶外作用"
        },
        {
          "source": "n_ot1",
          "target": "n_rp1",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与严重高甘油三酯血症相关的风险通路"
        },
        {
          "source": "n_rp1",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_adv1",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "该假设若成立，将会导致严重不良后果"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "score": 0.54,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Gemfibrozil 确有与严重高甘油三酯血症的禁忌关系"
        ],
        "caveats": [
          "未能解决 Skeptic 提出潜在的靶外作用与不良反应问题"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "score": 0.43,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Fibrates 对于严重高甘油三酯血症在某些情况下是禁忌"
        ],
        "caveats": [
          "缺乏针对风险路径的进一步数据支持"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "score": 0.4,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "Niacin 的确能导致甘油三酯升高作为禁忌"
        ],
        "caveats": [
          "需进一步验证其在高甘油三酯血症患者中的安全性"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Gemfibrozil contra Severe hypertriglyceridaemia",
          "reason": "清晰的禁忌关系以及与潜在不良反应的对应"
        }
      ],
      "remaining_gaps": [
        "Skeptic 指出风险通路与不良反应的联系尚未得到验证"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C"
          ],
          "impact_summary": "引入多个潜在禁忌药物，为决策提供了广泛背景"
        },
        {
          "round": 2,
          "seeds": [
            "D",
            "E"
          ],
          "impact_summary": "虽然补充了风险探讨，但需更深入的研究"
        }
      ],
      "lessons": [
        "禁忌药物明细清单需配合实际病例分析，以确认真正的临床风险",
        "确保 Skeptic 提出的质疑能够被严密关注以提升推荐的可靠性"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "针对每个假设提供至少一个量化的安全性评估数据以支持其关联"
      },
      {
        "role": "Skeptic",
        "patch": "填补风险路径与不良反应之间缺失的证据链，使用明确案例支撑"
      },
      {
        "role": "Explorer",
        "patch": "优先考虑新的药物机制性证据，并确保覆盖不同作用途径"
      }
    ],
    "heuristics": [
      {
        "when": "高甘油三酯血症患者",
        "then": "识别并列出所有已知药物的禁忌及其潜在影响"
      },
      {
        "when": "临床试验数据不足",
        "then": "聚焦于药物的真实世界数据与病例研究"
      }
    ]
  }
}